Ellis Levine
Papers
3
Total Citations
118
H-Index
3
About
Ellis Levine’s research is centered on improving treatment outcomes for muscle-invasive bladder cancer, with a particular focus on the role of neoadjuvant chemotherapy and surgical interventions. His major contributions include identifying predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy, a key factor in determining patient prognosis and guiding treatment decisions. This work, published in 2015, has garnered 61 citations, underscoring its influence in the field. Levine also explored the complex reasons behind avoidance, refusal, and abandonment of chemotherapy before and after cystectomy, shedding light on critical barriers to optimal care. In a multinational multicenter study, he demonstrated how suboptimal neoadjuvant chemotherapy dosing negatively impacts peri-operative outcomes and survival following robot-assisted radical cystectomy, a finding with direct clinical implications. His research has helped refine treatment protocols and improve patient selection for aggressive therapies. Levine’s work is essential reading for clinicians and researchers seeking to optimize multimodal treatment strategies for bladder cancer, and his studies are frequently cited in guidelines and subsequent clinical trials.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3